In this program, Foley attorneys Gordon Davenport, III and Ethan D. Lenz, along with Mary Duffy, Managing Director, Aon Private Equity & Transaction Solutions, discussed the insurance issues that can arise in the course of a deal, including the impact of representation and warranties (R&W) or other transactional insurance coverages. Specific topics included:
- What issues are commonly posed by a target’s third-party liability insurance coverage?
- How should you utilize the due diligence process to determine potential issues with a target’s insurance coverage?
- What different considerations are raised by “occurrence” vs. “claims made” policies?
- How should purchase-agreement provisions dealing with insurance matters be structured?
- What is R&W insurance coverage and what types are available to facilitate deals?
- How can R&W insurance and other transaction-liability insurance aid in getting a transaction completed?
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.